Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Cloud sales rep calls business prospect and says who he represents. Business prospect does google search and checks with leadership and returns with thanks but no thanks. Let me go with your competition with a competitive product without the headache. Buyout/ merger needed here 2021 imo $clwd
Definitely. If the AI and software product is as good as CLWD contends, a company such as Accenture could easily profit from it and expand on it. The name change is essential though. I can see one of CLWD’s salesman calling a Jeff Bezos company or any association of his (other big tech) and letting them know who they are representing and getting hung up on or shown the door at some point based on reputation alone and fierce competition. Companies that were to hire them would have to continually look at if they will lose big business because of the association. Reputations matter.
Associations and reputations mean alot in the business world and are not forgotten so easily. Like it or not, imo CloudCommerce with its current reputation (despite its trying to repair it), will not be receiving any govt contracts or from any entity associated with the government. Further, CLWD may call to do business but will be eliminated fast from the competition to do business with any Jeff Bezos or Bill Gates or other big business tech and marketing companies and their associations. Its just not going to happen and they probably know it. A buyout or merger is needed here for a new start hence the radio silence. All in my opinion. $clwd
New Covid19 strain spreading in UK. https://apple.news/AAONLEVeISXi4zgSSOPJCHA
CEO Cotropia states in previous pr
“we recognize that while other pharma companies may produce effective antibodies, there will necessarily be a need for additional monoclonal antibodies to be used in tantum with those initially discovered. Also, and unfortunately, the mutation of viruses, both the HIV and the CoronaVirus, will necessitate the production of numerous effective antibodies as the virus mutates around the therapeutics initially discovered.”
Cotropia’s statement indicates that pharm companies with their proprietary Mabs will need to team up with other pharm company Mabs to defeat Corona Virus due to mutation from virus escape. $enzc
Thanks warefaretrader. It seems this is a good time to accumulate with the email from the company representative stating exciting news in the new year. $clwd
Good point. I think they all must be feeling its time for a change with the politics of things. The look they have just might not be business advantageous at this point and perhaps a name change and a new start in a tax haven is just what they need.
Thanks Detached. I will buy the fear. I’m looking for a buyout. After all this company has been through over the last 4 years or so best for the execs to move on and call it a day. $clwd
Took a milly starter over the last couple weeks avg close to a cent. With Sello involved money talks bs walks. I like the logistics of things and malta location. The new pharm company adds value and sp moves nicely.
Its your get out of jail free card so to speak.
You were going to buy 50k anyway with the attorney letter how about 100k?
Picked up a milly at a penny and under over the last few days and will buy more if it goes under a cent again. Nash and co got the goods. Moxy on fire. $XALL
I was looking more for a flush in the 4’s but settled for 1.5 milly at .0055 toward the close today and will continue to buy more down here in the 4 and 5s. Lets get that pr on Monday and call it good. Thanks for the insights Warfaretrader. $CLWD
Custodianships don’t dilute. Retail taking profits. I like the ticker symbol- perhaps a group or incorporation involved. Patience. $AWGI
Until then, most are going by Moody and the great work he does to bring in value in these custodials.
Good job! The board needs to find out more about that merging business from Moody and any share count adjustments to be helpful. I called yesterday and confirmed he got it so at this point I believe they are allowed to talk about the merging business.
Once the value added business is known, which will be identified soon and most can agree Moody does a good job at finding good businesses, I will have a better idea of things through their market cap. GLTY
The merging company will add value -that is what you know. Need to find out from filings if there is an update to share count and what that value added business is going to be. If you go by the previous work of Moody-avg the two shells market caps that have merged already and use the OS from this shell it puts it over .40. DYODD and GLTY
Good to see you in this neck of the woods Papa Bear. Have some Water why dont you.
Thank you Benfica88
Loading Heavy
He got it. Confirmed over phone.
Zhabilov jr and ITV-1 taking center stage. I thought it would be more about Cotropia and Clone3 as it pertains to the science of things. The more consolidation under .10 the more we smash through it and leave it behind for good. All this work is not being done for a .10 cent company. Insiders taking care of business based on scientific developments yet to be fully revealed. Looking forward to progress reports. $enzc
Good interpretation of the semantics of things GKinvestor. ITV-1 is one piece of the puzzle. Clone3 is another and that is being researched at OWS and in France and Italy as prior pr’s have stated. Scientific breakthroughs (such as what was stated in the MS pr that just came out) can happen at any moment with good research. Stay tuned. $enzc
Good job! Huge loading today above .09 now. Cotropia and insiders buying big here- its in the filings. $enzc
Clone3 binds with ITV-1 but it’s not perfected yet as per previous pr stating side effects. The company has been transparent. Its great news Enzolytics is going after the side effects according to todays news. Its obvious you have been F’d on other stocks and taking it out here. GLTY
What has been made public is that they have made scientific developments based on combining their Clone3 Mab and ITV-1 technologies which will be made available by licensing for further study and use. Wishful thinking to believe they have a vaccine at this point. Doctors are researching now this science for therapeutic use so it is good to know that the Enzolytics patents are not simply just scientific per se without the chance to be put to real therapeutic use. What also has been made public is that their is variable debt that needs to be converted. Many times the pinks are a place where companies merge in order to take care of variable debt. Alot more to be revealed here. Keep an eye on the OS and AS as they are updated in the OTC. Day traders are robbing the newbies and panic sellers here daily for big money. We will see with future pr’s if Enzolytics will breakthrough the merging paperwork and hype with their licensing useful therapeutic science. All part of the story. $enzc
The article you are referring to is from seven years ago and Zhabilov jr has noted that there are ITV-1 side effects. As I understand currently ITV-1 is being binded with Mabs (from recovered patients) and tested further. Enzolytics has merged with BioClonetics due to new discoveries as per the pr’s.
As of Nov 20 this is interesting research in the field: “Because of ORBIT’s unique structure, Zha and his team have been working to develop a treatment for the coronavirus using antibodies from patients who have recovered from the virus. Through sophisticated technology called single B-cell cloning, the ORBIT team can sort through a recovered patient’s B-cells and identify the antibody that’s matched with the COVID-19 protein.
“The hope is these antibodies can neutralize the virus and prevent it from infecting more normal tissue,” Zha says. Using mouse models, they’ve already identified the COVID-19 target and established the methodology for next steps in the drug’s development.”
https://www.mdanderson.org/cancerwise/monoclonal-antibodies-and-cancer-treatment--what-to-know.h00-159386679.html
The work that was done in Sofia was a start but need those ITV-1 side effects taken care of- progress report on this next up! $enzc
Yes but times have changed and its being cleaned up. Harry has found a mentor in Charles now and the science works otherwise they would not have merged. The world is moving from the digital age to the molecular revolution. The next Microsoft will be found in the Microbiology field. Enzolytics is taking part. ITV-1 does have side effects as mentioned in a pr so that needs to be solved. Let’s go. $enzc
https://www.fiercebiotech.com/biotech/microsoft-partners-up-biotech-biological-computing-and-cell-dna-programming
Agreed. At this point, the risk to reward to invest in enzolytics is very good- there was nothing available down at the 200 ma. Morons sold in the 7’s and panic Friday close sellers were plentiful along with what cdel was doing. I added to my tankers last week. Any science related to a breakthrough at OWS or anywhere else in the world this science is being now researched further and the chase is on- should be close to a progress report. $enzc
With world famous researchers now working on the science enzc offers across the world due to the pandemic, we should be getting progress reports soon. This science has been available since the 1980’s and Zhabilov jr and Cotropia been working on it together for at least a year when jr moved out to plano. $enzc
The pr reads “The patent covers pharmaceutical compositions developed by the inventor Harry Zhabilov, CSO of the Company, which are suitable for the treatment of several disorders including certain immune disorders, congenital defects involving primary T cell deficiency, viral infections, HIV and immunosuppression following cancer treatment.”
Looking forward to Enzolytics putting out some more information about their science and technology targeting cancer- not only for the cause but any info at all could help generate substantial revenue and earnings.
https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/t-cell-deficiency
Good Catpole. Looking forward to enzc dropping contractual licensing business as some have said the billionaires are waiting on to invest. Patents are great but it seems they are a dime a dozen down here in the otc. Harry’s past business blunders are coming back to haunt enzc with conversions happening now. You can see cdel all day long with his hidden 10000 lot slaps- kept it down all yesterday and today into the news. Harry and Charlie need to be held to the fire to not reverse split on stockholders after they have been holding them up with all the bs Harry conversions. That would be Harry’s style from before though. Now its horses heads and camel toes though for him not like before. $enzc
The filing again is littered with Harry jr’s business abominations. They are probably converting into the news of every filing now. I believe the science takes enzc through for the win. Time will tell. $enzc
“As it relates to the CMO and production of the initial validation batch of our lead product ITV-1, which will be marketed in Europe as ImmunH through our partner, Immunotech Laboratories BG-Europe. This is for the treatment of HIV/Aids, and the validation batch production is for the purpose of Phase IV, as required by the regulatory agencies as part of the mass use permitting process. Upon a successful validation batch, the intention is for full commercialization in Eastern Europe initially, then expansion to additional markets. Enzolytics owns 49% of Immunotech Laboratories BG-Europe.” Immunotech Labs going to play a bigger role soon.
https://www.sec.gov/Archives/edgar/data/1421851/000107878220000273/f8k041520_ex99z1.htm
Intellectual property can be stolen. Since Enzolytics will be licensing their science to other companies, it could lead to another company finding other avenues with the science. I think they already have companies lined up hence the need to nail down the patent today. $enzc
You need to read up. The science that Enzolytics is now having further research done on at OWS is cutting edge and furthers what Zhabilov Sr did in Sofia. Cotropia and Zhabilov jr are binding the Mabs with ITV-1. Check back in at the end of the month. $enzc
Thanks Timing!
Looking forward to seeing some testimonials from big business ceo users of mjlink in order to establish credibility based on their experience.
Not sure about BioClonetics but Zhabilov jr had to take his prior company VG Life Sciences to court to make sure he held on to the ITV-1 patents and he did it because he knew they potentially could be worth billions. Although Jr made some bot so good decisions along the way, he gets huge respect for his perseverance when it comes to some steps he took to get to this point. $enzc